These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3545658)

  • 1. The role of 4-quinolones in the treatment of infections.
    Cynamon MH; Wilcox GH
    Compr Ther; 1987 Feb; 13(2):37-43. PubMed ID: 3545658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic contribution of the new quinolones].
    Wolff M
    Rev Prat; 1987 Apr; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the 4-quinolones.
    Eggleston M; Park SY
    Infect Control; 1987 Mar; 8(3):119-25. PubMed ID: 3553053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 5. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
    Hooper DC; Wolfson JS
    Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical use of the quinolones.
    Neu HC
    Lancet; 1987 Dec; 2(8571):1319-22. PubMed ID: 2890913
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical uses of nalidixic acid analogues: the fluoroquinolones.
    Høiby N
    Eur J Clin Microbiol; 1986 Apr; 5(2):138-40. PubMed ID: 3013628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of urinary tract infections. Clinical experience comparing norfloxacin to other quinolones].
    Fischetti G; Stillitani E; Michetti P; Massa P; Mastroberardino G
    Minerva Urol Nefrol; 1990; 42(4):211-3. PubMed ID: 2095636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
    Rugendorff EW
    Drugs; 1987; 34 Suppl 1():91-4. PubMed ID: 3481333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
    Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
    Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
    J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections.
    Kromann-Andersen B; Sommer P; Pers C; Larsen V; Rasmussen F
    Infection; 1986; 14 Suppl 4():S305-6. PubMed ID: 3546151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolones in the treatment of serious infections.
    Webster A; Gaya H
    Rev Infect Dis; 1988; 10 Suppl 1():S225-33. PubMed ID: 3279496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans.
    Mavromanolakis E; Maraki S; Cranidis A; Tselentis Y; Kontoyiannis DP; Samonis G
    Scand J Infect Dis; 2001; 33(6):477-8. PubMed ID: 11450873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients receiving quinolones and cyclosporine after heart transplantation.
    Robinson JA; Venezio FR; Costanzo-Nordin MR; Pifarre R; O'Keefe PJ
    J Heart Transplant; 1990; 9(1):30-1. PubMed ID: 2313417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical use of norfloxacin (Nolicin) and ciprofloxacin (Ciprinol)].
    Drinovec J
    Ter Arkh; 1992; 64(6):120-2. PubMed ID: 1440327
    [No Abstract]   [Full Text] [Related]  

  • 20. Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
    Pfau A; Sacks TG
    J Urol; 1993 Mar; 149(3):532-4. PubMed ID: 8437256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.